Human medicines European public assessment report (EPAR): Vyndaqel, tafamidis, Date of authorisation: 16/11/2011, Revision: 33, Status: Authorised

Human medicines European public assessment report (EPAR): Welireg, belzutifan, Date of authorisation: 12/02/2025, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Tenofovir disoproxil Viatris (previously Tenofovir disoproxil Mylan), tenofovir disoproxil, Date of authorisation: 08/12/2016, Revision: 25, Status: Authorised

Human medicines European public assessment report (EPAR): Poherdy, pertuzumab, Date of authorisation: 23/04/2026, Revision: 2, Status: Authorised

Outcome of written procedures finalised during the period from 04 June 2026 to 22 September 2026

Human medicines European public assessment report (EPAR): Iasibon, ibandronic acid, Date of authorisation: 21/01/2011, Revision: 14, Status: Authorised

EMA/PE/0000243861

EMA/PE/0000258095

EMA/PE/0000244980

EMA/PE/0000240600